documents: FDA-2019-N-2650-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-N-2650-0001 FDA FDA-2019-N-2650 Investigational New Drug Applications; Exemptions for Clinical Investigations To Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic Proposed Rule Amendment 2022-12-09T05:00:00Z 2022 12 2022-12-09T05:00:00Z 2023-03-10T04:59:59Z 2023-03-11T02:00:26Z 2022-26728 0 0 090000648552a62c

Links from other tables